Trials / Terminated
TerminatedNCT00687531
Clinical Trial to Assess Efficacy, Safety, Treatment Adherence and Quality of Life Impact of Mometasone Furoate in Asthmatic Patients (Study P04879)(TERMINATED)
Open Label, 12-week Clinical Trial to Assess Efficacy, Safety, Treatment Adherence and Quality of Life Impact of Mometasone Furoate Dry Powder 400 mcg Once-daily in Persistent Mild-moderate Asthmatic Patients at Least 12 Years Old
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 385 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
Open label, 12-week clinical trial to assess efficacy, safety, treatment adherence and Quality of Life impact of Mometasone Furoate dry powder 400 mcg once-daily in persistent mild-moderate asthmatic patients at least 12 years old. Protocol deviations may have occurred that resulted in quality issues associated with reporting of the data.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mometasone Furoate | Mometasone Furoate 400 mcg once daily, in the evening through 12 weeks. |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2008-05-30
- Last updated
- 2024-05-24
- Results posted
- 2011-07-20
Source: ClinicalTrials.gov record NCT00687531. Inclusion in this directory is not an endorsement.